
Brenda Libby Coleman
Examiner (ID: 13884, Phone: (571)272-0665 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 2611, 1624, 1611 |
| Total Applications | 3154 |
| Issued Applications | 1967 |
| Pending Applications | 488 |
| Abandoned Applications | 741 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18215218
[patent_doc_number] => 11590131
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Compositions and methods for treating galactosemia
[patent_app_type] => utility
[patent_app_number] => 16/634509
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 16305
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16634509
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/634509 | Compositions and methods for treating galactosemia | Jul 26, 2018 | Issued |
Array
(
[id] => 16190772
[patent_doc_number] => 20200231621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => CRYSTALLINE OR AMORPHOUS FORM OF STEROID DERIVATIVE FXR AGONIST, PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/633111
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633111
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633111 | Crystalline or amorphous form of steroid derivative FXR agonist, preparation method therefor and use thereof | Jul 25, 2018 | Issued |
Array
(
[id] => 16190773
[patent_doc_number] => 20200231622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => METHOD FOR PREPARING STEROID DERIVATIVE FXR AGONIST
[patent_app_type] => utility
[patent_app_number] => 16/633122
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633122
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633122 | Method for preparing steroid derivative FXR agonist | Jul 25, 2018 | Issued |
Array
(
[id] => 16854862
[patent_doc_number] => 20210155607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => INTERMEDIATES USEFUL FOR THE SYNTHESIS OF A SELECTIVE INHIBITOR AGAINST PROTEIN KINASE AND PROCESSES FOR PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/633756
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633756
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633756 | Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same | Jul 24, 2018 | Issued |
Array
(
[id] => 17286245
[patent_doc_number] => 11202783
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-21
[patent_title] => Use of aminoalkylbenzothiazepine derivatives
[patent_app_type] => utility
[patent_app_number] => 16/631611
[patent_app_country] => US
[patent_app_date] => 2018-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 4426
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16631611
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/631611 | Use of aminoalkylbenzothiazepine derivatives | Jul 19, 2018 | Issued |
Array
(
[id] => 17496458
[patent_doc_number] => 11285141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Composition and methods for the treatment of myopia
[patent_app_type] => utility
[patent_app_number] => 16/632105
[patent_app_country] => US
[patent_app_date] => 2018-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10846
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632105
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632105 | Composition and methods for the treatment of myopia | Jul 19, 2018 | Issued |
Array
(
[id] => 13536531
[patent_doc_number] => 20180319809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/039877
[patent_app_country] => US
[patent_app_date] => 2018-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16039877
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/039877 | Fused quadracyclic compounds, compositions and uses thereof | Jul 18, 2018 | Issued |
Array
(
[id] => 15927867
[patent_doc_number] => 20200155567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => TREATMENT OF CANCERS USING A COMBINATION COMPRISING PARP INHIBITORS, TEMOZOLOMIDE AND/OR RADIATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/630103
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630103
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630103 | TREATMENT OF CANCERS USING A COMBINATION COMPRISING PARP INHIBITORS, TEMOZOLOMIDE AND/OR RADIATION THERAPY | Jul 16, 2018 | Abandoned |
Array
(
[id] => 13504611
[patent_doc_number] => 20180303848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => SUBSTITUTED TRIAZOLOBENZODIAZEPINES
[patent_app_type] => utility
[patent_app_number] => 16/025512
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025512
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/025512 | Substituted triazolobenzodiazepines | Jul 1, 2018 | Issued |
Array
(
[id] => 15293405
[patent_doc_number] => 20190389838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => BENZAZEPINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/480842
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -55
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480842 | Benzazepine derivatives | Jun 28, 2018 | Issued |
Array
(
[id] => 16985438
[patent_doc_number] => 11072594
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => Trioxolane agents
[patent_app_type] => utility
[patent_app_number] => 16/625237
[patent_app_country] => US
[patent_app_date] => 2018-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 63886
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 267
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625237
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625237 | Trioxolane agents | Jun 26, 2018 | Issued |
Array
(
[id] => 13504547
[patent_doc_number] => 20180303816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => SALTS AND COMPOSITIONS USEFUL FOR TREATING DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/019265
[patent_app_country] => US
[patent_app_date] => 2018-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16019265
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/019265 | SALTS AND COMPOSITIONS USEFUL FOR TREATING DISEASE | Jun 25, 2018 | Abandoned |
Array
(
[id] => 15963075
[patent_doc_number] => 20200165289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF OBETICHOLIC ACID AND DERIVATIVES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/632304
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632304 | Process and intermediates for the synthesis of obeticholic acid and derivatives thereof | Jun 21, 2018 | Issued |
Array
(
[id] => 14684817
[patent_doc_number] => 20190241523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => THERAPEUTIC COMPOUNDS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/010717
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010717
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/010717 | THERAPEUTIC COMPOUNDS AND COMPOSITIONS | Jun 17, 2018 | Abandoned |
Array
(
[id] => 18003484
[patent_doc_number] => 20220362250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => METHODS OF TREATING BRAIN TUMORS USING COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/619526
[patent_app_country] => US
[patent_app_date] => 2018-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619526
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619526 | Methods of treating brain tumors using combination therapy | Jun 11, 2018 | Issued |
Array
(
[id] => 15383641
[patent_doc_number] => 10532992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-14
[patent_title] => Prodrugs of urolithins and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/005160
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 8861
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005160
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/005160 | Prodrugs of urolithins and uses thereof | Jun 10, 2018 | Issued |
Array
(
[id] => 14883405
[patent_doc_number] => 10421728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Peptide nucleic acid monomer and a preparation method
[patent_app_type] => utility
[patent_app_number] => 16/003304
[patent_app_country] => US
[patent_app_date] => 2018-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3077
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16003304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/003304 | Peptide nucleic acid monomer and a preparation method | Jun 7, 2018 | Issued |
Array
(
[id] => 15827095
[patent_doc_number] => 20200128829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => Antimicrobial Compounds
[patent_app_type] => utility
[patent_app_number] => 16/619555
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619555
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619555 | Antimicrobial Compounds | Jun 6, 2018 | Abandoned |
Array
(
[id] => 16799033
[patent_doc_number] => 10993948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-04
[patent_title] => RNA polymerase I inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/996544
[patent_app_country] => US
[patent_app_date] => 2018-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 25064
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996544
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996544 | RNA polymerase I inhibitors and uses thereof | Jun 3, 2018 | Issued |
Array
(
[id] => 17697052
[patent_doc_number] => 11370762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Vinylarene derivative and application
[patent_app_type] => utility
[patent_app_number] => 16/489815
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19761
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489815
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489815 | Vinylarene derivative and application | May 30, 2018 | Issued |